Getting to the heart of it: Improving cardiovascular and renal outcomes in adults with Chronic kidney disease and Type 2 Diabetes

  • Zeh, P. (Speaker)
  • Faizal Osman (Invited speaker)

Activity: Talk or presentationOral presentation


Presentation Objectives:

• Recognise the burden of Chronic kidney disease (CKD) and understand the imperative for prompt and effective management
• Review key data from the EMPA-KIDNEY and EMPA-REG OUTCOME trials
• Recognise the cardio-renal-metabolic benefits of Jardiance® (empagliflozin)
• Understand the guideline recommendations around reducing cardiovascular and renal risk through the use of SGLT2 inhibitors in adults with CKD and type 2 diabetes (T2D)
• Be confident in knowing when and how to initiate empagliflozin in adults with CKD and T2D.
Period18 Apr 2024
Event titleThe Boehringer Ingelheim and Lilly Alliance Education Meetings
Event typeSeminar
LocationCoventry, United KingdomShow on map
Degree of RecognitionLocal